Mimi Liu, MD
Retina Specialist · Englewood, CONPI 1568469625
Payments from drug & device makers
Across 341 payments — averaging $6380.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Genentech, Inc.$2M
- Roche TCRC, Inc.$155K
- AbbVie$38K
- US Retina LLC$15K
- F. Hoffmann-la Roche AG$4K
- Genentech USA, Inc.$608
- plus $1K from 13 others
Across 6 payments — averaging $2093.32 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- F. Hoffmann-la Roche AG$13K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Genentech, Inc. | 212 | $1,961,245 |
| Roche TCRC, Inc. | 24 | $154,885 |
| AbbVie(2 entities) | 23 | $37,671 |
| US Retina LLC | 8 | $15,430 |
| F. Hoffmann-la Roche AG | 2 | $4,470 |
| Genentech USA, Inc. | 26 | $608 |
| Regeneron Healthcare Solutions, Inc. | 8 | $222 |
| Alimera Sciences, Inc. | 4 | $164 |
| Hoffmann-la Roche Limited | 1 | $140 |
| Novartis | 8 | $131 |
| Astellas Pharma US Inc | 5 | $125 |
| Coherus Oncology, Inc. | 5 | $120 |
| Biogen | 5 | $105 |
| Eyepoint US, Inc. | 1 | $85 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 1 | $75 |
| Harrow Eye, LLC | 3 | $62 |
| Neurotech Pharmaceuticals, Inc. | 2 | $56 |
| Sun Pharmaceutical Industries Inc. | 2 | $39 |
| Bausch & Lomb Americas Inc. | 1 | $24 |
How this compares
$2,175,657 in reported general payments places this provider in the 95th percentile of 51 retina specialist providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other retina specialist in Englewood
- Sara HaugDurango$9.5M
- James LuuColorado Springs$2.9M
- Murtaza AdamParker$2.1M
- Ramin SarrafizadehColorado Springs$1.7M
- Brian JoondephDenver$1.6M
- Mark ChittumColorado Springs$1.2M
- Stanford TaylorColorado Springs$879K
- Nancy ChristmasDenver$775K
- Scott OliverAurora$590K
- Alan KimuraDenver$546K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.